Updated Jul 16, 2026
Cohen Joshua B is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $3.10M.

Joshua B. Cohen is the Co-Chief Executive Officer of Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing therapies for neurodegenerative diseases. He has been involved in the company's operations and strategic direction since its inception.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-09 | AMLX | Amylyx Pharmaceuticals, Inc. | A — Grant or award | 248.9K | $0.00 | |
| 2026-03-04 | AMLX | Amylyx Pharmaceuticals, Inc. | S — Open-market sale | 29.3K | $14.48 | $424K |
| 2026-02-04 | AMLX | Amylyx Pharmaceuticals, Inc. | S — Open-market sale | 15.5K | $14.68 | $228K |
| 2026-01-21 | AMLX | Amylyx Pharmaceuticals, Inc. | S — Open-market sale | 2.0K | $13.83 | $27K |
| 2026-01-21 | AMLX | Amylyx Pharmaceuticals, Inc. | M — Option exercise | 2.8K | $7.57 | $21K |
| 2026-01-21 | AMLX | Amylyx Pharmaceuticals, Inc. | S — Open-market sale | 136.2K | $13.59 | $1.85M |
| 2026-01-21 | AMLX | Amylyx Pharmaceuticals, Inc. | M — Option exercise | 197.2K | $7.57 | $1.49M |
| 2026-01-08 | AMLX | Amylyx Pharmaceuticals, Inc. | S — Open-market sale | 7.7K | $11.09 | $86K |
| 2025-09-30 | AMLX | Amylyx Pharmaceuticals, Inc. | S — Open-market sale | 200 | $15.00 | $3K |
| 2025-09-30 | AMLX | Amylyx Pharmaceuticals, Inc. | S — Open-market sale | 29.7K | $14.34 | $426K |
| 2024-10-02 | AMLX | Amylyx Pharmaceuticals, Inc. | S — Open-market sale | 18.6K | $3.20 | $59K |
Joshua B. Cohen is the Co-Chief Executive Officer of Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing therapies for neurodegenerative diseases. He has been involved in the company's operations and strategic direction since its inception.…
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($3.10M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cohen Joshua B profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.